{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:05:23Z","timestamp":1785762323114,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[1999,2,12]],"date-time":"1999-02-12T00:00:00Z","timestamp":918777600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1038\/sj.bjc.6690188","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T14:03:06Z","timestamp":1032271386000},"page":"1179-1181","source":"Crossref","is-referenced-by-count":212,"title":["A high incidence of vertebral fracture in women with breast cancer"],"prefix":"10.1038","volume":"79","author":[{"given":"J A","family":"Kanis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E V","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Powles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A H G","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Spector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1999,2,12]]},"reference":[{"key":"BF6690188_CR1","unstructured":"Breast Cancer Task Force. Treatment Committee. National Cancer Institute, Breast Cancer (1977). Suggested protocol guidelines for combination chemotherapy trials and for combined modality trials. Washington, DC, US Department of Health, Education and Welfare. Publication no. (NIH) 77\u20131192."},{"key":"BF6690188_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/8756-3282(95)00442-4","volume":"18","author":"P Filipponi","year":"1996","unstructured":"Filipponi, P., Christallini, S., Rizzello, E., Policani, G., Fedeli, L. & Gregorio, F. et al (1996). Cyclical intravenous clodronate in postmenopausal osteoporosis. Results of a long-term trial. Bone 18: 179\u2013184.","journal-title":"Bone"},{"key":"BF6690188_CR3","first-page":"445","volume":"5","author":"JL Hayward","year":"1978","unstructured":"Hayward, J. L., Meakin, J. W. & Stewart, H. J. (1978). Assessment of response and recurrence in breast cancer. Semin Oncol 5: 445\u2013449.","journal-title":"Semin Oncol"},{"key":"BF6690188_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S8756-3282(96)00285-2","volume":"19","author":"JA Kanis","year":"1996","unstructured":"Kanis, J. A., Powles, T., Paterson, A. H. G., McCloskey, E. V. & Ashley, S. (1996). Clodronate decreases the frequency of skeletal metastases in women with breast cancer. Bone 19: 663\u2013667.","journal-title":"Bone"},{"key":"BF6690188_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/BF01623782","volume":"7","author":"JA Kanis","year":"1997","unstructured":"Kanis, J. A., Delmas, P., Burckhardt, P. Cooper, C. & Torgerson D., on behalf of the EFFO (1997). Guidelines for the diagnosis and management of osteoporosis. Osteoporosis Int 7: 390\u2013406.","journal-title":"Osteoporosis Int"},{"key":"BF6690188_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/BF01623275","volume":"3","author":"EV McCloskey","year":"1993","unstructured":"McCloskey, E. V., Spector, T. D., Eyres, K. S., Fern, D. E., O\u2019Rourke, N., Vasikaran, S. & Kanis, J. A. (1993). The assessment of vertebral deformity \u2013 a method for use in population studies and clinical trials. Osteoporosis Int 3: 138\u2013147.","journal-title":"Osteoporosis Int"},{"key":"BF6690188_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1210\/edrv-10-4-476","volume":"10","author":"JJ Orloff","year":"1989","unstructured":"Orloff, J. J., Wu, T. L. & Stewart, A. F. (1989). Parathyroid hormone-like proteins: biochemical responses and receptor interactions. Endocrinol Rev 10: 476\u2013495.","journal-title":"Endocrinol Rev"},{"key":"BF6690188_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1200\/JCO.1993.11.1.59","volume":"11","author":"AHG Paterson","year":"1993","unstructured":"Paterson, A. H. G., Powles, T. J., Kanis, J. A., McCloskey, E., Hanson, J. & Ashley, S. (1993). Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 11: 59\u201365.","journal-title":"J Clin Oncol"},{"key":"BF6690188_CR9","first-page":"3059","volume":"51","author":"GJ Powell","year":"1991","unstructured":"Powell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J. A. & Henderson, M. A. et al (1991). Localisation of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51: 3059\u20133061.","journal-title":"Cancer Res"},{"key":"BF6690188_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","volume":"14","author":"TJ Powles","year":"1996","unstructured":"Powles, T. J., Hickish, T., Kanis, J. A., Tidy, A. & Ashley, S. (1996). The effect of tamoxifen on lumbar bone mineral density in pre- and postmenopausal women. J Clin Oncol 14: 78\u201384.","journal-title":"J Clin Oncol"},{"key":"BF6690188_CR11","doi-asserted-by":"crossref","unstructured":"Powles, T. J., McCloskey, E., Paterson, A. H. G., Ashley, S., Tidy, A. & Kanis, J. A. (1997). Oral clodronate reduces the loss of bone mineral density in women with operable primary breast cancer. J Clin Oncol, submitted for publication, ASBMR abstract,","DOI":"10.1093\/jnci\/90.9.704"},{"key":"BF6690188_CR12","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1001\/jama.1988.03720140043031","volume":"259","author":"AS Rivkees","year":"1988","unstructured":"Rivkees, A. S. & Crawford, J. D. (1988). The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 259: 2123\u20132125.","journal-title":"JAMA"},{"key":"BF6690188_CR13","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1200\/JCO.1997.15.4.1341","volume":"15","author":"T Saarto","year":"1997","unstructured":"Saarto, T., Blomqvist, C., Valimaki, M., Makelo, P., Sarna, S. & Elomaa, I. (1997). Chemical castration induced by adjuvant cyclophosphamide, methotrexate and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomised study in premenopausal breast cancer patients. J Clin Oncol 15: 1341\u20131347.","journal-title":"J Clin Oncol"},{"key":"BF6690188_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/jbmr.5650080707","volume":"8","author":"TD Spector","year":"1993","unstructured":"Spector, T. D., McCloskey, E., Doyle, D. V. & Kanis, J. A. (1993). Prevalence of vertebral fractures in women and the relationship with bone density and symptoms. The Chingford study. J Bone Miner Res 8: 817\u2013822.","journal-title":"J Bone Miner Res"},{"key":"BF6690188_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/8756-3282(94)90703-X","volume":"15","author":"T Taube","year":"1994","unstructured":"Taube, T., Elomaa, I., Blomqvist, C., Beneton, M. N. C. & Kanis, J. A. (1994). Histomorphometric evidence for osteoclast mediated bone resorption in metastatic breast cancer. Bone 15: 161\u2013166.","journal-title":"Bone"},{"key":"BF6690188_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0021-9681(87)90061-0","volume":"40","author":"JP Utz","year":"1987","unstructured":"Utz, J. P., Melton, L. J., Kan, S. H. & Riggs, B. L. (1987). Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study. J Chron Dis 40: 105\u2013113.","journal-title":"J Chron Dis"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690188","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:51:06Z","timestamp":1684414266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2,12]]},"references-count":16,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["BF6690188"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690188","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2,12]]}}}